These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38263869)

  • 1. Clinically significant findings in a decade-long retrospective study of prenatal chromosomal microarray testing.
    Olayiwola JO; Marhabaie M; Koboldt D; Matthews T; Siemon A; Mouhlas D; Porter T; Kyle G; Myers C; Mei H; Hou YC; Babcock M; Hunter J; Schieffer KM; Akkari Y; Reshmi S; Cottrell C; Mathew MT; Leung ML
    Mol Genet Genomic Med; 2024 Mar; 12(3):e2349. PubMed ID: 38263869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort.
    Su J; Qin Z; Fu H; Luo J; Huang Y; Huang P; Zhang S; Liu T; Lu W; Li W; Jiang T; Wei S; Yang S; Shen Y
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):226-233. PubMed ID: 34090309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.
    Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H
    Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of expanded non-invasive prenatal screening compared with chromosomal microarray analysis in over 8000 pregnancies without major structural anomaly.
    Maya I; Salzer Sheelo L; Brabbing-Goldstein D; Matar R; Kahana S; Agmon-Fishman I; Klein C; Gurevitch M; Basel-Salmon L; Sagi-Dain L
    Ultrasound Obstet Gynecol; 2023 Jun; 61(6):698-704. PubMed ID: 36776119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal microarray analysis and prenatal diagnosis.
    Lo JO; Shaffer BL; Feist CD; Caughey AB
    Obstet Gynecol Surv; 2014 Oct; 69(10):613-21. PubMed ID: 25336071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-nucleotide polymorphism-based chromosomal microarray analysis provides clues and insights into disease mechanisms.
    Daum H; Meiner V; Hacohen N; Zvi N; Eilat A; Drai-Hasid R; Yagel S; Zenvirt S; Frumkin A
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):655-660. PubMed ID: 30693591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of chromosome microarray analysis in prenatal diagnosis.
    Xia M; Yang X; Fu J; Teng Z; Lv Y; Yu L
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):696. PubMed ID: 33198662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit versus risk of chromosomal microarray analysis performed in pregnancies with normal and positive prenatal screening results: A retrospective study.
    Moshonov R; Hod K; Azaria B; Abadi-Korek I; Berger R; Shohat M
    PLoS One; 2021; 16(4):e0250734. PubMed ID: 33901244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal Genetic Diagnosis of Fetal Cystic Hygroma: A Retrospective Single-Center Study from China.
    Zhou Y; Lu X; Zhang Y; Ge Y; Xu Y; Wu L; Jiang Y
    Cytogenet Genome Res; 2022; 162(7):354-364. PubMed ID: 36907182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies.
    Sagi-Dain L; Cohen Vig L; Kahana S; Yacobson S; Tenne T; Agmon-Fishman I; Klein C; Matar R; Basel-Salmon L; Maya I
    Genet Med; 2019 Nov; 21(11):2462-2467. PubMed ID: 31123319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies.
    Li R; Wan J; Zhang Y; Fu F; Ou Y; Jing X; Li J; Li D; Liao C
    Ultrasound Obstet Gynecol; 2016 Jan; 47(1):53-7. PubMed ID: 26033469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal chromosomal microarray analysis reveals high proportion of copy-number variants in low-risk pregnancies.
    Stern S; Hacohen N; Meiner V; Yagel S; Zenvirt S; Shkedi-Rafid S; Macarov M; Valsky DV; Porat S; Yanai N; Frumkin A; Daum H
    Ultrasound Obstet Gynecol; 2021 May; 57(5):813-820. PubMed ID: 32202684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis.
    Mademont-Soler I; Morales C; Soler A; Martínez-Crespo JM; Shen Y; Margarit E; Clusellas N; Obón M; Wu BL; Sánchez A
    Ultrasound Obstet Gynecol; 2013 Apr; 41(4):375-82. PubMed ID: 23233332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a DNA method, QF-PCR, in the prenatal diagnosis of fetal aneuploidies.
    Langlois S; Duncan A; ;
    J Obstet Gynaecol Can; 2011 Sep; 33(9):955-960. PubMed ID: 21923994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis.
    Hillman SC; McMullan DJ; Hall G; Togneri FS; James N; Maher EJ; Meller CH; Williams D; Wapner RJ; Maher ER; Kilby MD
    Ultrasound Obstet Gynecol; 2013 Jun; 41(6):610-20. PubMed ID: 23512800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of chromosome microarray analysis and karyotyping in diagnostic assessment of abnormal Down syndrome screening results.
    Kang H; Wang L; Li X; Gao C; Xie Y; Hu Y
    BMC Pregnancy Childbirth; 2022 Nov; 22(1):813. PubMed ID: 36333674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities.
    Fiorentino F; Napoletano S; Caiazzo F; Sessa M; Bono S; Spizzichino L; Gordon A; Nuccitelli A; Rizzo G; Baldi M
    Eur J Hum Genet; 2013 Jul; 21(7):725-30. PubMed ID: 23211699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.